Published: 25 January 2024
Author(s): Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Kazuhisa Kaneda, Kazunori Mushiake, Kazushige Kadota, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takeshi Kimura, COMMAND VTE Registry-2 Investigators
Issue: May 2024
Section: Original Article

Cancer remains a progressive disease with a high mortality despite of multidisciplinary treatment. However, many patients with cancer have recently been living longer owing to advancement in early diagnosis and treatment for cancer [1,2]. Therefore, complications that arise during the course of cancer treatment have become increasingly clinically relevant. Cancer is a strong risk factor for the development of venous thromboembolism (VTE), which was reported to occur at a 7-fold higher rate in patients with cancer compared to those without [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.